NYSEAMERICAN:MLSS - Milestone Scientific Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.00
  • Forecasted Upside: 8.70 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$3.68
▼ -0.03 (-0.81%)
1 month | 3 months | 12 months
Get New Milestone Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLSS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLSS

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$4.00
▲ +8.70% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Milestone Scientific in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 8.70% upside from the last price of $3.68.
Buy
The current consensus among 2 investment analysts is to buy stock in Milestone Scientific. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/15/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/14/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/13/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/11/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/9/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/8/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/6/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
3/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
9/16/2020Northland SecuritiesInitiated CoverageMarket Perform
i
8/17/2020Maxim GroupReiterated RatingBuy$4.00
i
Rating by Anthony Vendetti at Maxim Group
6/23/2020Maxim GroupReiterated RatingBuy$4.00
i
Rating by Anthony Vendetti at Maxim Group
5/19/2020Maxim GroupReiterated RatingBuy$3.00
i
Rating by Anthony Vendetti at Maxim Group
4/1/2020Maxim GroupReiterated RatingBuy$3.00
i
Rating by Anthony Vendetti at Maxim Group
11/15/2019Maxim GroupReiterated RatingBuy$2.00
i
Rating by Anthony Vendetti at Maxim Group
10/18/2019Maxim GroupReiterated RatingBuy$2.00
i
Rating by Anthony Vendetti at Maxim Group
8/16/2019Maxim GroupReiterated RatingBuy$1.00
i
11/16/2018Maxim GroupLower Price TargetBuy ➝ Buy$3.00 ➝ $1.50
i
4/4/2018Maxim GroupReiterated RatingBuy$4.00
i
11/15/2017Maxim GroupReiterated RatingBuy$4.00
i
10/6/2017Maxim GroupReiterated RatingBuy$4.00
i
8/15/2017Maxim GroupReiterated RatingBuy$4.00
i
6/13/2017Maxim GroupReiterated RatingBuy$4.00
i
6/12/2017Maxim GroupReiterated RatingBuy$4.00
i
12/31/2016Maxim GroupLower Price TargetBuy$5.00 ➝ $4.00
i
12/23/2016Maxim GroupLower Price TargetBuy$5.00 ➝ $4.00
i
(Data available from 3/8/2016 forward)
Milestone Scientific logo
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent System that are used to control the flow rate of the anesthesia during the injection, which allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; and CompuMed for use in various medical applications, such as plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Further, the company offers Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
Read More

Today's Range

Now: $3.68
$3.41
$3.80

50 Day Range

MA: $1.89
$1.47
$2.31

52 Week Range

Now: $3.68
$0.85
$4.40

Volume

31,056 shs

Average Volume

835,779 shs

Market Capitalization

$234.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.54

Frequently Asked Questions

What sell-side analysts currently cover shares of Milestone Scientific?

The following Wall Street research analysts have issued reports on Milestone Scientific in the last year: Maxim Group, Northland Securities, and Zacks Investment Research.
View the latest analyst ratings for MLSS.

What is the current price target for Milestone Scientific?

1 Wall Street analysts have set twelve-month price targets for Milestone Scientific in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 8.7%. Maxim Group has the highest price target set, predicting MLSS will reach $4.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $4.00 for Milestone Scientific in the next year.
View the latest price targets for MLSS.

What is the current consensus analyst rating for Milestone Scientific?

Milestone Scientific currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MLSS will outperform the market and that investors should add to their positions of Milestone Scientific.
View the latest ratings for MLSS.

What other companies compete with Milestone Scientific?

How do I contact Milestone Scientific's investor relations team?

Milestone Scientific's physical mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier's listed phone number is (973) 535-2717. The official website for Milestone Scientific is www.milesci.com.